Please login to the form below

Not currently logged in
Email:
Password:

R&D costs push up ALK Abello's Q2 FY07 pre-tax losses

Danish pharmaceutical company ALK Abello has posted a Q2 FY07 pre-tax loss of DKK 29m (USD 5.3m), an increase on a Q2 FY06 loss of DMK 24m, due to increased costs for R&D and sales and marketing.

Danish pharmaceutical company ALK Abello has posted a Q2 FY07 pre-tax loss of DKK 29m (USD 5.3m), an increase on a Q2 FY06 loss of DMK 24m, due to increased costs for R&D and sales and marketing.

SME Direkt analysts had expected a pre-tax loss of DKK 15m (USD 2.7m).

Sales increased 11 per cent to reach DKK 373m (USD 67.5m), down slightly on market expectations of DMK 377m (USD 68.3m).

The group posted an operating loss of DKK 35m (USD 6.3m), compared with DKK 31m in Q2 FY06 and was below expectations for a DMK 24m (USD 4.4m) loss.

ALK Abello reiterated its previous FY07 sales guidance of approximately DKK 1.7bn (USD 307.8m) and a pre-tax profit of DKK 230 to DKK 250m (USD 41.7m to USD 45.3m).

The company said the launch of its tablet-based grass pollen allergy vaccine Grazax was progressing according to plan. Sales of the drug amounted to DKK 19m (USD 3.4m) in H1 FY07.

ALK Abello said its year-on-year increase in costs for sales, marketing and administration was related to Grazax, while continuing development of the vaccine also augmented R&D costs.

Sales growth in the period was helped by an active allergy season, according to the firm.

22nd August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics